Dr. Xiao-Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
402022 Main Street
4TH floor
Flushing, NY 11354Phone+1 347-532-2888Fax+1 718-321-8620
Summary
- Dr. Helen Xiao-Li, Board certified in Radiation Oncology, was awarded her medical degree from Peking Union Medical College, the most prestigious medical school in China. In 1995, with a special interest in cancer research, she obtained a Ph.D. degree in Pharmacology from Yale University School of Medicine, New Haven, Connecticut.
Dr. Xiao-Li completed her Radiation Oncology training at Montefiore Medical Center-Albert Einstein College of Medicine, New York, N.Y. She has received a research award from the New York Roentgen Society and the AACR Travel Award from the American Association for Cancer Research during these years.
Dr Xiao-Li worked as an attending physician for 21st Century Oncology for 10 years and Flushing Radiation Oncology/Cyberknife Center for 2 years. She is familiar with 3D-CRT, IMRT, IGRT, stereotactic radiosurgery (SRS), Fractionated Stereotactic Radiotherapy (SRT), and stereotactic body radiotherapy (SBRT) for the treatment of variety of malignancies and certain benign conditions.
With extensive experience for SRS/SRT and SBRT using Gamma Knife and Cyberknife, Dr. Xiao-Li will bring her expertise to further strengthen our SRS/SRT and SBRT program using our most innovative Varian Rapid-Arc beam system.
She is bilingual and fluent in Mandarin Chinese.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Radiation Oncology, 1998 - 2002
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1996 - 1997
- Peking Union Medical CollegeClass of 1987
Certifications & Licensure
- NY State Medical License 2002 - 2026
- IN State Medical License 2024 - 2025
- WA State Medical License 2024 - 2025
- PA State Medical License 2024 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- ResearchAward New York Roentgen Society, 1999
- AACR travel award American Association for Cancer Research, 1995
Publications & Presentations
PubMed
- 15 citations7-Hydroxystaurosporine (UCN-01) preferentially sensitizes cells with a disrupted TP53 to gamma radiation in lung cancer cell lines.Helen H. Xiao, Yan Makeyev, James Butler, Bhadrasain Vikram, William A. Franklin
Radiation Research. 2002-07-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: